BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2019 11:25:18 AM | Browse: 825 | Download: 1209
 |
Received |
|
2019-03-17 09:23 |
|
Peer-Review Started |
|
2019-03-18 09:25 |
|
To Make the First Decision |
|
2019-04-17 00:20 |
|
Return for Revision |
|
2019-04-17 02:16 |
|
Revised |
|
2019-05-10 15:11 |
|
Second Decision |
|
2019-05-17 09:03 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-05-18 12:44 |
|
Articles in Press |
|
2019-05-18 12:44 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-07-13 11:40 |
|
Publish the Manuscript Online |
|
2019-07-14 11:25 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli and Nicola Coppola |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Caterina Sagnelli, MD, PhD, Assistant Professor, Associate Professor, Chief Doctor, Reader (Associate Professor), Department of Mental Health and Public Medicine, Section of Infectious Diseases, University of Campania Luigi Vanvitelli, Via L. Armanni 5, Naples 80135, Italy. caterina.sagnelli@unicampania.it |
| Key Words |
Hepatitis B virus reactivation; Hepatitis B virus infection; Hemo-lymphoproliferative diseases; Immunosuppressive therapy; Hepatitis B virus therapy; Hepatitis B virus prophylasis |
| Core Tip |
Hepatitis B virus (HBV) reactivation frequently exerts a negative impact on the outcome of patients with hemo-lymphoproliferative disorders both by liver injury, at times severe, and a premature delay or termination of immunosuppressive treatments. Patients at risk should be identified by screening of HBV serum markers before immunosuppressive therapy is started. The use of HBV nucle(t)side analogues, as treatment or prophylaxis, is effective in limiting the frequency and intensity of the damage caused. Antivirals should be administered 2-3 wk before starting immunosuppressive treatment, for the entire immunosuppressive period and during post-treatment follow-up, the length of which depends on the intensity of immunosuppression reached. |
| Publish Date |
2019-07-14 11:25 |
| Citation |
Sagnelli C, Pisaturo M, Calò F, Martini S, Sagnelli E, Coppola N. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World J Gastroenterol 2019; 25(26): 3299-3312 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i26/3299.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i26.3299 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
